CollPlant (CLGN) Biotechnologies announced the expansion of its distribution footprint into North America through a new partnership with a U.S.-based logistics center. Scheduled to become operational this quarter, the logistics hub will provide full cGMP-compliant storage and distribution services and will serve as a clinical supply depot. This expansion will support CollPlant’s growing customer base for its rhCollagen and BioInk product lines in both the U.S. and Canada. The new U.S. logistics center features state-of-the-art infrastructure, including cGMP-controlled storage environments, a cloud-based temperature monitoring system, advanced emergency back-up capabilities, AI-powered security, and remote inventory management. These capabilities ensure reliable, efficient, and secure distribution to meet the quality and regulatory expectations of CollPlant’s partners and customers.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLGN:
- CollPlant’s BioInk Outperforms Matrigel in Technion Study
- CollPlant’s Collink.3D shows strong performance vs. Matrigel in study
- CollPlant and Mayo Clinic Unveil Humanized 3D Bioprinted Skin Model
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
- Why Is Collplant Stock (CLGN) Down 25% Today?
